Highlights Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:02 17/04/2026 BST			5-day change	1st Jan Change
234.18 ^USD	-0.15%		-1.79%	+13.16%

04-18	US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims	RE
04-17	U.S. judge rejects Bayer's request for injunction to block Johnson & Johnson's alleged false statements about prostate cancer drug	RE

Highlights

04-18	US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims	RE
04-17	U.S. judge rejects Bayer's request for injunction to block Johnson & Johnson's alleged false statements about prostate cancer drug	RE
04-16	MeiraGTx Acquires Bota-vec From Johnson & Johnson; Reports Positive Three-Year Early-Stage Data From AAV-hAQP1 Program in Xerostomia	MT
04-16	US FDA's accelerated approval for drugs needs more transparency, says research firm	RE
04-15	BofA Securities Raises Price Target on Johnson & Johnson to $254 From $253, Maintains Neutral Rating	MT
04-15	Johnson & Johnson Q1 Reinforces Growth Outlook on New Product Cycle, Morgan Stanley Says	MT
04-15	Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal	RE
04-15	Poolbeg Pharma plc Receives Clinical Trial Authorisation for Polb 001 Topical Trial	CI
04-14	Wall Street rallies on renewed hopes for US-Iran talks, earnings boost	RE
04-14	Equities Rise Intraday, Oil Falls Amid US-Iran Talk Optimism	MT
04-14	Wall St rallies on hopes for renewed US-Iran talks, earnings boost	RE
04-14	Johnson & Johnson Raises Quarterly Dividend, Payable on June 9, 2026	CI
04-14	Wall St jumps on Mideast de-escalation hopes; earnings in focus	RE
04-14	Johnson & Johnson Raises 2026 Outlook Following First-Quarter Beat	MT
04-14	Global markets live: JPMorgan Chase, Amazon, Wells Fargo, Chevron, Blackrock…
04-14	Wall St indexes set to open higher on Mideast de-escalation hopes, earnings in focus	RE
04-14	J&J says working towards a mid 2027 separation for orthopedic business: conf call	RE
04-14	Betting on Restraint
04-14	Johnson & Johnson Reports Earnings Results for the First Quarter Ended March 29, 2026	CI
04-14	Stocks Rise Pre-Bell Amid Hopes of Renewed US-Iran Peace Talks; Big Bank Earnings, PPI Data on Deck	MT
04-14	Wall St rallies on hopes for renewed US-Iran talks, earnings boost	RE
04-14	Johnson & Johnson Increases Quarterly Dividend to $1.34 a Share, Payable June 9 to Stockholders of Record May 26	MT
04-14	Genmab Posts Higher Darzalex Net Sales in Q1	MT
04-14	Johnson & Johnson Extends Royal Dividend Status With 3.1% Boost	DJ
04-14	Johnson & Johnson's Q1 Adjusted Earnings Fall, Revenue Rises: Adjusts Full Year Outlook	MT